@misc{indiciae8dd131d9fda2,
  title = {Deficiencies in the Fanconi Anemia or the Homologous Recombination Pathway enhance the antitumor effects of the novel hypoxia-activated prodrug CP-506},
  author = {Schuitmaker, L. and van der Wiel, A. M. A. and Lieuwes, N. G. and Biemans, R. and Mutsters, N. A. M. and Jung, J. and Claudino Bastos, V. and Prades Sagarra, E. and Kuang, S. and Langie, S. A. S. and Setton, J. and Theys, J. and Yaromina, A. and Dubois, L. J. and Lambin, P.},
  year = {2025},
  doi = {10.1101/2025.05.21.655302},
  url = {https://www.biorxiv.org/content/10.1101/2025.05.21.655302v1},
  note = {Source identifier: 10.1101/2025.05.21.655302}
}